Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Pure red cell aplasia

Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease The Use of Trifluoperazine in Transfusion Dependent DBA Tacrolimus Treatment for Refractory Autoimmune Cytopenia Sirolimus Treatment for Refractory PRCA Tacrolimus Treatment for Refractory PRCA A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure